“Osteo Relief Institute”- Treating Arthritis Pain Non-Surgically with Skill and Compassion

Introduction – Pain from arthritis can be debilitating and crippling. Many patients with arthritis experience unrelenting pain and decreased range of motion which severely impacts their mobility and ultimately adversely impacts their quality of life. Osteo Relief Institute can provide the relief they seek from pain and limited mobility allowing them to return to more normal activities using safe, non-surgical techniques in a professional environment with compassionate skilled physicians.


Definition – There are more than 100 types of arthritis with more than 50 million adults in the United States suffering from some form of arthritis. Arthritis is more common among females with frequency increasing with age. In addition, arthritis is the leading cause of disability in the United States . Risk factors for osteoarthritis include excess weight, a positive family history, and a previous injury.


OsteoarthritisOsteoarthritis which is also known as Degenerative Joint Disease or “wear and tear” arthritis is the most common type of arthritis. It is characterized by a wearing down and degeneration of the cartilage that covers the ends of bones in a joint space. As the cartilage wears away, bones rub against bones leading to the characteristic symptoms of pain, swelling, and stiffness. Over time the joints tend to weaken with the condition becoming chronic. There is no current cure for osteoarthritis.


“Osteo Relief Institute”Osteo Relief Institute was founded on June 1, 2012, to provide non-surgical relief for patients with arthritis through specialized joint injections. Osteo Relief Institute specializes in the treatment of arthritis of the knee, grinding knee syndrome, locking or catching of the knee, pain when using stairs and swelling of the lower joints.


The Institute is made up of a multidisciplinary team comprised of Board Certified Physicians and Physical Therapists (http://releasefact.com/2017/08/the-osteo-relief-institute-provides-more-solutions-for-managing-osteoarthritis-joint-pain/). Utilizing a new FDA approved all natural joint lubrication injection, many conditions can be successfully treated including osteoarthritis of the knee, chronic back pain, herniated and bulging discs, spinal stenosis, severe neck pain, sciatica, degenerative disc disease and failed back surgery.


In addition, at the “Osteo Relief Institute”, advanced biomechanical bracing techniques are also utilized in conjunction with the joint lubrication to restore normal biomechanical function. This helps to maintain healthy joint mobility and normal range of motion (WeeklyOpinion).


There is hope to avoid surgery and its potential complications and the many side effects of medications by seeking treatment and relief through the talented professionals at the “Osteo Relief Institute.”


Jim Tananbaum Introduces Molly He to Foresite Capital for A Better Health Care System

Foresite Capital recently announced its new development on an additional staff member. It is undisputed that for an organization to prosper in business, sometimes new blood with exceptional talent will serve a great purpose. The introduction of Dr. Molly He to Foresite Capital will be a great stride of success to the healthcare sector. She brings to Foresite Capital fifteen years of experience in the medical care industry.


According to INC42, the chief executive officer of Foresite Capital, Molly He’s experience will be useful in developing drugs for patients through his company. Dr. He brings to Foresite in –depth scientific research and results on genomics and drug development. Jim Tananbaum added that her excellence in leadership would be valuable to Foresite Capital because the company is looking forward to diversifying its operations and portfolios in transformational ways. She is an alumnus of Illumina. She was the scientist in charge of Illumina’s protein reagent innovation as well as improvements.


In an article on Biz Journals, before she joined Illumina, Molly was in charge of sciences at the Pacific Biosciences company. In this company, she was in charge of the reagent development in the department of single molecular sequencing chemistry. She spent her first ten years of career in the industry of pharmaceuticals. Her focus was based on the organic base and design of antibody. She worked on cancer-related drugs. Dr. Molly He went to the University of Nankai for a degree in biochemistry and later joined the University of California for a Ph.D. after specializing in protein biophysics.

Jim’s Profile

Jim Tananbaum is a career executive and entrepreneur. He is the chief executive officer of Foresite Capital, a firm that is dedicated to building healthcare leaders by offering financial support. Before joining Foresite Capital, he was a founding partner at Prospect Ventures Partners. With Foresite Capital as his main success story, Jim has been the talk of the Midas list on Forbes. Three times in a row, he has made it through public recognition. Other investments that have contributed to this recognition are Amira Pharmaceuticals, Amerigroup, and Jazz Pharmaceuticals. At Foresite Capital, he has diversified the portfolio of the company to cover patients and physicians. Under his insight, Foresite Capital has partnered with organizations committed to making the health care sector a better service provider.

Click here: https://www.linkedin.com/in/jim-tananbaum-a7562a7/